Union health ministry officials on Thursday clarified that the intent of the Indian Council of Medical Research director general's letter envisaging the launch of COVID-19 vaccine by August 15 was......
An estimated one crore frontline health workers will received the first dose of COVID-19 vaccine whenever it becomes available, with around 92 per cent of government hospitals and 55 per cent of......
Pfizer India has become the first pharmaceutical firm to seek from the Drugs Controller General of India an emergency use authorisation for its COVID-19 vaccine in the country, after its parent......
Getting vaccinated for COVID-19 will be voluntary, the Union health ministry has said while underlining that the vaccine introduced in India will be as effective as any vaccine developed by other......
Prime Minister Narendra Modi on Saturday unveiled an ambitious National Digital Health Mission under which every Indian will get a health ID that will ease access to medical services and also......
Zydus Cadila Healthcare Ltd on Tuesday said it has received approval from the French regulatory agency, AFSSAPS, to market Sertraline capsules 25 mg and 50 mg, in the French market.Sertraline is an......
Cadila Healthcare Ltd has announced that Zydus Cadila has received its very first approval from USFDA to market Atenolol, an anti-hypertensive drug, in the US market. Following this, the group......
Cadila Healthcare Ltd has informed BSE that pursuant to Order dated January 31, 2003 passed by Hon'ble High Court of Gujarat in the matter of approval of Scheme of Amalgamation of German Remedies......
Cadila Healthcare Ltd board approved amalgamation of German Remedies Ltd, Recon Healthcare Ltd, Zydus Pathline Ltd & Zoom Properties Ltd with the company.The boards of Cadila Health Care and German......
Cadila Healthcare Ltd said on Thursday, said German Remedies, a part of the Zydus Group, has launched Fludara Oral (Fludarabine) in the Indian market for the treatment of chronic lymphocytic......